Antithrombotic Reversal Agents. [Review]
Citation: Hematology - Oncology Clinics of North America. 31(6):1147-1157, 2017 DecPMID: 29078928Institution: MedStar Washington Hospital CenterDepartment: Emergency MedicineForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Anticoagulants/ae [Adverse Effects] | *Emergency Medical Services/mt [Methods] | *Fibrinolytic Agents/tu [Therapeutic Use] | *Hemorrhage | Anticoagulants/tu [Therapeutic Use] | Hemorrhage/ci [Chemically Induced] | Hemorrhage/di [Diagnosis] | Hemorrhage/th [Therapy] | HumansYear: 2017Local holdings: Available online from MWHC library: 1996 - presentISSN:- 0889-8588
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 29078928 | Available | 29078928 |
Available online from MWHC library: 1996 - present
Copyright (c) 2017 Elsevier Inc. All rights reserved.
The actively bleeding anticoagulated patient presenting to the emergency department requires rapid evaluation and treatment, which is made increasingly complicated by the ever-evolving antithrombotic treatment options used in medicine. Even with excellent supportive care, the timeliness with which reversal decisions need to be made continues to demand of the emergency practitioner a familiarity with the properties and general characteristics of a variety of antithrombotic agents. Reversal options vary and may include vitamin K, FFP, PCC, rFVIIa, platelets, and desmopressin, among others.
English